Procedures and devices for bariatric and metabolic endoscopy

Orlandini, Beatrice; Gallo, Camilla; Boškoski, Ivo; Bove, Vincenzo; Costamagna, Guido

doi:10.1177/2631774520925647

Cited by 8 publications

(6 citation statements)

References 108 publications

(164 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the last decade, bariatric endoscopy procedures have emerged as a minimally invasive alternative to surgery. 96 Endoscopic therapies include duodenal and gastric devices, such as intragastric balloons. 97 98 Safety of these procedures is likely higher than that of surgery, but data in patients with advanced chronic liver disease/cirrhosis is lacking, and more research is needed to clarify the real risk and benefits in these patients.…”

Section: Alternatives To Bs In Patients With Cirrhosismentioning

confidence: 99%

Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases

et al. 2021

View full text Add to dashboard Cite

The burden of obesity and metabolic syndrome has determined a sharp increase in bariatric surgery (BS) procedures, which lead to marked weight loss, improved metabolic syndrome, reduced cardiovascular risk, and even improvement in nonalcoholic steatohepatitis (NASH). Despite these promising results, BS in patients with chronic liver disease can rarely lead to worsening of liver function, progression to cirrhosis and its complications, and even liver transplantation. On the other hand, since obesity in patients with cirrhosis is a major cofactor for progression to a decompensated stage of the disease and a risk factor for hepatocellular carcinoma, BS has been used to achieve weight loss in this population. In this review, we critically analyze the existing data on outcomes of BS in patients with cirrhosis and the possible mechanisms leading to fibrosis progression and worsening liver function in patients undergoing BS. Finally, we propose a set of measures that could be taken to improve the multidisciplinary management of liver disease in patients undergoing BS, including early recognition of malnutrition and alcohol misuse.

show abstract

Section: Alternatives To Bs In Patients With Cirrhosismentioning

confidence: 99%

Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases

et al. 2021

View full text Add to dashboard Cite

show abstract

“…68 Apollo OverStitch Suturing System creates a restrictive sleeve. It applies full-thickness sutures alongside the stomach's greater curvature through a double-channel therapeutic gastroscope 79,80 (Figure 3). It reduces the functional capacity of the stomach and increases satiety.…”

Section: Botulinum Toxin a Recent Reports Have Suggested That Botulinum Toxin A (Btx-a) Can Help Losementioning

confidence: 99%

Endobariatric procedures for obesity: clinical indications and available options

Goyal

Kopel

Perisetti

et al. 2021

Clin Med Insights Gastroenterol

View full text Add to dashboard Cite

Obesity remains a growing public health epidemic that has increased healthcare costs and related comorbidities. Current treatment guidelines encourage a multidisciplinary approach starting from patient selection, interventions, and long-term follow-up to maintain weight loss. However, these conservative interventions are largely ineffective at reducing body weight due to low adherence to the treatment regimen. Recently, endoscopic bariatric therapies have become an attractive alternative to traditional invasive bariatric surgeries due to their improved efficacy, safety, and cost-effectiveness. Endoscopic bariatric therapies include intragastric balloon placement, endoscopic sleeve gastroplasty, gastric bypass revision, and aspiration therapy. These procedures fall into two separate categories depending on the primary mechanism involved: restrictive or malabsorptive. Restrictive methods, such as the Orbera® and ReShape™ intragastric balloons, increase satiation and delay gastric emptying while decreasing the amount of food that can be ingested. In contrast, malabsorptive devices, such as the EndoBarrier®, interfere with the small intestine’s ability to absorb food while restoring normal gastrointestinal hormone levels regulating satiation. Together, these techniques provide useful alternatives for patients in whom pharmacological or lifestyle modifications have proven ineffective. Despite these advantages, the long-term effects of these procedures on metabolic changes remain to be studied. Furthermore, the management of complications from these procedures continues to evolve. In this review, we aim to elaborate on the clinical indications and efficacy of the endobariatric procedures, together with various types of available endoscopic bariatric therapy procedures.

show abstract

“…Bariatric endoscopy encompasses an emerging group of minimally invasive endoscopic procedures used to achieve weight loss in obese patients by limiting caloric intake through mechanical restriction of the stomach (Table 4) (30)(31)(32)(33)(34)(35)(36)(37)(38). Like bariatric surgery, these procedures reduce the gastric capacity for ingested meals and promote early satiety, but are less invasive, require a shorter hospital stay, and can be performed in patients who are not surgical candidates (32).…”

Section: Bariatric Endoscopymentioning

confidence: 99%

Interventional Radiology Obesity Therapeutics: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel

Yuan

Latif

Shafaat

et al. 2021

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

The Society of Interventional Radiology Foundation commissioned a Research Consensus Panel to establish a research agenda on "Obesity Therapeutics" in interventional radiology (IR). The meeting convened a multidisciplinary group of physicians and scientists with expertise in obesity therapeutics. The meeting was intended to review current evidence on obesity therapies, familiarize attendees with the regulatory evaluation process, and identify research deficiencies in IR bariatric interventions, with the goal of prioritizing future high-quality research that would move the field forward. The panelists agreed that a weight loss of >8%-10% from baseline at 6-12

show abstract

Procedures and devices for bariatric and metabolic endoscopy

Cited by 8 publications

References 108 publications

Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases

Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases

Endobariatric procedures for obesity: clinical indications and available options

Interventional Radiology Obesity Therapeutics: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel

Contact Info

Product

Resources

About